Correlation Between Mangoceuticals, Common and NexGel Warrant
Can any of the company-specific risk be diversified away by investing in both Mangoceuticals, Common and NexGel Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangoceuticals, Common and NexGel Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mangoceuticals, Common Stock and NexGel Warrant, you can compare the effects of market volatilities on Mangoceuticals, Common and NexGel Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangoceuticals, Common with a short position of NexGel Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangoceuticals, Common and NexGel Warrant.
Diversification Opportunities for Mangoceuticals, Common and NexGel Warrant
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mangoceuticals, and NexGel is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals, Common Stock and NexGel Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NexGel Warrant and Mangoceuticals, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangoceuticals, Common Stock are associated (or correlated) with NexGel Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NexGel Warrant has no effect on the direction of Mangoceuticals, Common i.e., Mangoceuticals, Common and NexGel Warrant go up and down completely randomly.
Pair Corralation between Mangoceuticals, Common and NexGel Warrant
Given the investment horizon of 90 days Mangoceuticals, Common is expected to generate 2.56 times less return on investment than NexGel Warrant. But when comparing it to its historical volatility, Mangoceuticals, Common Stock is 3.17 times less risky than NexGel Warrant. It trades about 0.09 of its potential returns per unit of risk. NexGel Warrant is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 48.00 in NexGel Warrant on September 1, 2024 and sell it today you would earn a total of 2.00 from holding NexGel Warrant or generate 4.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Mangoceuticals, Common Stock vs. NexGel Warrant
Performance |
Timeline |
Mangoceuticals, Common |
NexGel Warrant |
Mangoceuticals, Common and NexGel Warrant Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mangoceuticals, Common and NexGel Warrant
The main advantage of trading using opposite Mangoceuticals, Common and NexGel Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangoceuticals, Common position performs unexpectedly, NexGel Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NexGel Warrant will offset losses from the drop in NexGel Warrant's long position.Mangoceuticals, Common vs. Profound Medical Corp | Mangoceuticals, Common vs. Si Bone | Mangoceuticals, Common vs. Nevro Corp | Mangoceuticals, Common vs. Paragon 28 |
NexGel Warrant vs. Nexgel Inc | NexGel Warrant vs. NLS Pharmaceutics AG | NexGel Warrant vs. NeuroSense Therapeutics Ltd | NexGel Warrant vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |